Skip to main content
WeightCited

CLA para Obesity

B

Cochrane meta-analysis of 18 RCTs (n=807) found CLA at 3.2 g/day reduced body fat mass by 1.33 kg over 6-12 months without significant change in body weight, suggesting lean mass preservation. A 2-year RCT (n=134) found sustained fat reduction. Effects are modest and require long-term use.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dcla\u0026condition\u003Dobesity'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            B

        

        

            
Conclusão

            
            
Cochrane meta-analysis of 18 RCTs (n=807) found CLA at 3.2 g/day reduced body fat mass by 1.33 kg over 6-12 months without significant change in body weight, suggesting lean mass preservation. A 2-year RCT (n=134) found sustained fat reduction. Effects are modest and require long-term use.

            
            
        

    











    
    

        
        

            

  
Key Statistics





            


    

        
18

        
Estudos

    

    

        
807

        
Participantes

    

    

        
            
            ↑
            
        
        
Positive

    

    

        B

        
Nota

    




        


        
        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
Dosagens Comumente Utilizadas

                

                    
                    

                        
general:

                        
3.2-6.4 g/day mixed isomers

                    

                    
                    

                        
bodycomposition:

                        
3.4 g/day (50:50 c9,t11:t10,c12 blend)

                    

                    
                    

                        
minimumeffective:

                        
3.2 g/day for ≥12 weeks

                    

                    
                

                
                

                    Limite superior: 6 g/day; higher doses may worsen insulin sensitivity
                

                
            

            

            

            
            

                Melhor horário: With meals; divide dose across 2-3 meals
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
Efeitos Colaterais Relatados

                    
    
                        
                        
  • 
                            ⚠
                            GI discomfort
                        
    • 
                        
                        
  • 
                            ⚠
                            May worsen insulin sensitivity at high doses
                        
    • 
                        
                        
  • 
                            ⚠
                            Possible HDL reduction
                        
    • 
                        
                        
  • 
                            ⚠
                            Fatty liver (in some rodent studies)
                        
    • 
                        
                    

                

                

                
                

                    
Interações Conhecidas

                    
    
                        
                        
  • 
                            ●
                            Diabetes medications (may affect insulin sensitivity)
                        
    • 
                        
                        
  • 
                            ●
                            Blood thinners (theoretical)
                        
    • 
                        
                    

                

                

                
                

                    

                        Ingestão máxima tolerável: 6 g/day; higher doses may worsen insulin sensitivity
                    

                

                
            

            

                Consulte sempre o seu profissional de saúde antes de iniciar qualquer suplemento.Sempre consulte seu profissional de saúde antes de iniciar qualquer suplemento.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does CLA help with Obesity?
            
        
        

            Based on 18 studies with 807 participants, there is moderate evidence from clinical studies that CLA may support Obesity management. Our evidence grade is B (Good Evidence).
        

    

    
    

        
            How much CLA should I take for Obesity?
            
        
        

            Studies have used various dosages. A commonly studied range is 3.2-6.4 g/day mixed isomers. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of CLA?
            
        
        

            Reported side effects may include GI discomfort, May worsen insulin sensitivity at high doses, Possible HDL reduction, Fatty liver (in some rodent studies). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for CLA and Obesity?
            
        
        

            We rate the evidence as Grade B (Good Evidence). This rating is based on 18 peer-reviewed studies with 807 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                
                

                
            

        

        

    


    
    












    

        Aviso Legal da FDA:
        Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.